Science
Mechanism of Action
Glyceollins function on multiple fronts to improve skin health. Their primary action involves significant depigmenting activity achieved by inhibiting melanin synthesis and crucial melanogenic enzymes such as tyrosinase. They further downregulate the expression of tyrosinase and tyrosinase-related protein-1 (TRP-1), and suppress intracellular cyclic AMP (cAMP) levels stimulated by α-MSH or Stem Cell Factor (SCF). Mechanistically, glyceollins reduce the expression of SCF and SOX10, along with decreasing downstream c-kit and p44/42 ERK phosphorylation, pathways integral to melanogenesis. Beyond pigmentation control, glyceollins exhibit anti-inflammatory properties by attenuating NF-κB activation and phosphorylation, thereby inhibiting pro-inflammatory cytokine production. Additionally, they demonstrate antioxidative capabilities.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 In laboratory settings, Glyceollin I extended yeast chronological lifespan by up to 40% at an optimal concentration of 12.5 nM, showing superior bioactivity compared to its isomers II and III in cancer cell models.
- 02 In vitro studies on B16 melanoma cells demonstrated that glyceollins effectively inhibited melanin synthesis and tyrosinase activity without cytotoxicity. Furthermore, they dose-dependently inhibited SCF-induced melanogenesis in B16F10 melanoma cells and reduced pigmentation in in vivo zebrafish embryo models.
Transparency
Dusting Analysis
No data available to suggest Glyceollins are commonly 'dusted' or used below effective thresholds in cosmetic formulations.
The Formula
Formulation
Stability
Glyceollins are characterized by oil solubility, indicated by their successful dissolution in organic solvents such as 80% ethanol for purification. Optimal pH and comprehensive stability data are not specified.
Safety
Safety Profile
Glyceollins are soybean-derived phytoalexins, suggesting a natural origin. However, the Cosmetic Ingredient Review (CIR) Expert Panel has not specifically reviewed glyceollins, and no safety assessment by SCCS was found. While promising, the toxicity at specific cosmetic concentrations and the safety of long-term topical exposure in humans require thorough determination. The FDA does not approve cosmetic ingredients (except color additives); manufacturers bear the responsibility for product safety.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Glyceollins show compelling in vitro and some in vivo (zebrafish) evidence for depigmenting, anti-inflammatory, and antioxidative benefits, making them a promising target for advanced skincare formulations; however, a lack of human topical clinical efficacy data and formal safety assessments (CIR/SCCS) necessitates further research before widespread adoption.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources